Rheumatic immune-related adverse events (9780443294006)
Sorry, but you already have a basket with that name. Please use something else.

Rheumatic immune-related adverse events
Centerfold image
Backcover image
Additional image

Rheumatic immune-related adverse events

In this issue of Rheumatic Disease Clinics, guest editors Drs. Alexa Simon Meara and David Liew bring their considerable expertise to the topic of Rheumatic Immune-Related Adverse Events. Immune checkpoint inhibitors sometimes cause rheumatic-disease-like symptoms, or rheumatic immune-related advers...

Series  The clinics. Internal medicine

Format  Hardback

ISBN  9780443294006

Publication Date  28 May 2024

£95.99

RRP £95.99

Please create an account to check availability. Please note that Peters does not supply to private individuals.

Quantity

ADD TO BASKET

Add to wishlist

to view our ratings for this title.
  • Our review
  • Details

Notes

to view our full review.

Summary

In this issue of Rheumatic Disease Clinics, guest editors Drs. Alexa Simon Meara and David Liew bring their considerable expertise to the topic of Rheumatic Immune-Related Adverse Events. Immune checkpoint inhibitors sometimes cause rheumatic-disease-like symptoms, or rheumatic immune-related adverse events (irAEs). In this issue, top experts discuss the utility of laboratory investigations for rheumatic irAEs; the future of biomarkers in rheumatic irAEs; integrating rheumatic irAE research and care into an oncological milieu; patient voices in rheumatic irAE care and research; polymyalgia rheumatica irAEs; inflammatory arthritis irAEs: current approaches to management; and more.Contains 15 relevant, practice-oriented topics including myositis irAEs; sicca symptom irAEs; de novo connective tissue disorders as irAEs; imaging in rheumatic irAEs; combining biologic DMARDs with immune checkpoint inhibitors; the impact of DMARDs and glucocorticoids on cancer response to immune checkpoint inhibitors; and more.


Provides in-depth clinical reviews on rheumatic immune-related adverse events, offering actionable insights for clinical practice.
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Contents

Pre
-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune
-Related Adverse Events, and Cancer Progression
Mimickers of Immune Checkpoint Inhibitor
-induced Inflammatory Arthritis
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events
The Current and Future of Biomarkers of Immune Related Adverse Events
Immunotherapy Toxicity Management in Clinical Practice: Building the Clinical Infrastructure for Immune
-related Adverse Event Evaluation and Care
Patient Voices in Rheumatic Immune
-related Adverse Events
Immune Checkpoint Inhibitor
-induced Polymyalgia Rheumatica
Immune Checkpoint Inhibitor
-induced Inflammatory Arthritis: Current Approaches to Management
Immune Checkpoint Inhibitor
-induced Myositis
Immune Checkpoint Inhibitor
-induced Sicca Syndrome
De novo Connective Tissue Disorders as Immune
-related Adverse Events
Imaging in Rheumatic Immune
-related Adverse Events
The Need for Classification Criteria of Immune Checkpoint Inhibitor
-induced inflammatory Arthritis: A Scoping Review
Impact of Non
-steroidal Anti
-inflammatory Drugs, Glucocorticoids, and Disease[1]Modifying Anti
-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy

Category
ANF
Language
English
Dewey
616.723
Reading age
to view reading age.
Interest Level
to view interest age.
Series
Publisher
Imprint
Pub. date
28 May 2024
Edition
Import
ISBN
9780443294006
BIC code
Binding
Hardback
Pages
240
Width
152mm
Height
229mm
Index
No
Contents page
Yes
Glossary
No
CE Mark
No
Product dimensions
A1A2A3A4A5A6229mm (h) x 152mm (w)

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.

More Info